These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30042369)

  • 1. Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis.
    Millan-Billi P; Serra C; Alonso Leon A; Castillo D
    Med Sci (Basel); 2018 Jul; 6(3):. PubMed ID: 30042369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course and management of idiopathic pulmonary fibrosis.
    Quinn C; Wisse A; Manns ST
    Multidiscip Respir Med; 2019; 14():35. PubMed ID: 31827795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.
    Suzuki A; Kondoh Y
    Respir Investig; 2017 Mar; 55(2):94-103. PubMed ID: 28274539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive and practical approach to the management of idiopathic pulmonary fibrosis.
    Moran-Mendoza O; Colman R; Kalluri M; Cabalteja C; Harle I
    Expert Rev Respir Med; 2019 Jul; 13(7):601-614. PubMed ID: 31177864
    [No Abstract]   [Full Text] [Related]  

  • 5. Clusters of comorbidities in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Rasmussen F; Bendstrup E
    Respir Med; 2021; 185():106490. PubMed ID: 34130097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue.
    Caminati A; Lonati C; Cassandro R; Elia D; Pelosi G; Torre O; Zompatori M; Uslenghi E; Harari S
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31578211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel management strategies for idiopathic pulmonary fibrosis.
    Ahmad K; Nathan SD
    Expert Rev Respir Med; 2018 Oct; 12(10):831-842. PubMed ID: 30136607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.
    Oldham JM; Collard HR
    Front Med (Lausanne); 2017; 4():123. PubMed ID: 28824912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to manage costs in idiopathic pulmonary fibrosis.
    Owens GM
    Am J Manag Care; 2017 Jul; 23(11 Suppl):S191-S196. PubMed ID: 28978214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities.
    King CS; Nathan SD
    Lancet Respir Med; 2017 Jan; 5(1):72-84. PubMed ID: 27599614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidities and Complications in Idiopathic Pulmonary Fibrosis.
    Cano-Jiménez E; Hernández González F; Peloche GB
    Med Sci (Basel); 2018 Aug; 6(3):. PubMed ID: 30200249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic pulmonary fibrosis: Clinical behavior and aging associated comorbidities.
    Buendía-Roldán I; Mejía M; Navarro C; Selman M
    Respir Med; 2017 Aug; 129():46-52. PubMed ID: 28732835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic Pulmonary Fibrosis: A Review of Disease, Pharmacological, and Nonpharmacological Strategies With a Focus on Symptoms, Function, and Health-Related Quality of Life.
    Rozenberg D; Sitzer N; Porter S; Weiss A; Colman R; Reid WD; Shapera S; Fisher J; Wentlandt K
    J Pain Symptom Manage; 2020 Jun; 59(6):1362-1378. PubMed ID: 31887400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
    Kolek V; Vašáková M; Šterclová M; Cwiertka K; Vrána D; Kudláček A; Skřičková J; Pešek M; Petera J
    Klin Onkol; 2017; 30(4):303-306. PubMed ID: 28832178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of idiopathic pulmonary fibrosis (IPF) and evidence-based guidelines.
    Sharif R
    Am J Manag Care; 2017 Jul; 23(11 Suppl):S176-S182. PubMed ID: 28978212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing comorbidities in idiopathic pulmonary fibrosis.
    Fulton BG; Ryerson CJ
    Int J Gen Med; 2015; 8():309-18. PubMed ID: 26451121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
    Raghu G; Amatto VC; Behr J; Stowasser S
    Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of idiopathic pulmonary fibrosis: an unmet public health need.
    Lee AS; Mira-Avendano I; Ryu JH; Daniels CE
    Respir Med; 2014 Jul; 108(7):955-67. PubMed ID: 24780718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Palliative Care in Reducing Symptoms and Improving Quality of Life for Patients with Idiopathic Pulmonary Fibrosis: A Review.
    Zou RH; Kass DJ; Gibson KF; Lindell KO
    Pulm Ther; 2020 Jun; 6(1):35-46. PubMed ID: 32048243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives on management of idiopathic pulmonary fibrosis.
    Puglisi S; Torrisi SE; Vindigni V; Giuliano R; Palmucci S; Mulè M; Vancheri C
    Ther Adv Chronic Dis; 2016 Mar; 7(2):108-20. PubMed ID: 26977280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.